Denver CO 黑色素瘤临床试验
19项针对 黑色素瘤的研究正在 Denver及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
招募中1 期
- Presbyterian/St Lukes Medical Center, Denver
- Sarah Cannon Research Institute at HealthONE, Denver
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
招募中3 期
- The Melanoma And Skin Cancer Institute, Englewood · 距离 6 英里
Pan-tumor MRD Study
招募中观察性研究
- The Melanoma and Skin Cancer Institute, Englewood · 距离 6 英里
R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors
招募中1 期
- Sarah Cannon Research Institute, Denver
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
招募中2 期
- The Women's Imaging Center, Denver
- Colorado Blood Cancer Institute, Denver
- Presbyterian - Saint Lukes Medical Center - Health One, Denver
- 以及另外 6 项
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
招募中1/2 期
- Skin Cancer Institute, Englewood · 距离 6 英里
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- AdventHealth Porter, Denver
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
招募中1 期
- Sarah Cannon Research Institute Denver, Denver
Project: Every Child for Younger Patients With Cancer
招募中观察性研究
- Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center, Denver
A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel
招募中1/2 期
- SCRI Oncology Partners- Denver, Denver
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
招募中1/2 期
- SCRI - Denver, Denver
Neoadjuvant Darovasertib in Primary Uveal Melanoma
招募中3 期
- The Melanoma and Skin Cancer Institute, Englewood · 距离 6 英里
A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
招募中2/3 期
- University of Colorado, Denver
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
招募中1 期
- Sarah Cannon Research Institute at Health ONE, Denver
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
招募中2/3 期
- The Melanoma & Skin Cancer Institute, Englewood · 距离 6 英里
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
招募中观察性研究
- Kaiser Permanente-Franklin, Denver
- Colorado Blood Cancer Institute, Denver
- Rocky Mountain Cancer Centers-Midtown, Denver
- 以及另外 1 项
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Denver
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
招募中1/2 期
- HealthONE Clinic Services Oncology - Hematology, LLC d/b/a Sarah Cannon Research Institute at HealthONE, Denver
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
招募中1/2 期
- Sarah Cannon Research Institute at HealthONE, Denver
其他城市的 黑色素瘤试验
- Houston, TX59 项研究
- New York City, NY38 项研究
- Los Angeles, CA34 项研究
- Nashville, TN32 项研究
- Pittsburgh, PA31 项研究
- Boston, MA25 项研究
- Philadelphia, PA23 项研究
- San Francisco, CA22 项研究
- Atlanta, GA21 项研究
- Columbus, OH21 项研究
- Salt Lake City, UT21 项研究
- Durham, NC21 项研究
Denver的其他研究
- 转移性癌症29 项研究
- 乳腺癌28 项研究
- 非小细胞肺癌27 项研究
- 多发性骨髓瘤26 项研究
- 结直肠癌23 项研究
- 癌症（所有类型）19 项研究
- 前列腺癌19 项研究
- 卵巢癌16 项研究
- 子宫内膜癌16 项研究
- 肺癌16 项研究
- 非霍奇金淋巴瘤14 项研究
- 胰腺癌13 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月1日。每项研究自行设定入选标准，由研究团队决定谁能参与。